Clinical studies, Cytostatic anticancer agents, Design, Phase I, Phase II, Phase III
dx.doi.org/10.1016/S1040-8428(00)00055-X, hdl.handle.net/1765/67716
Critical Reviews in Oncology / Hematology
Department of Medical Oncology

Eskens, F.A.L.M, & Verweij, J. (2000). Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: Facing the challenge of a proper study design. Critical Reviews in Oncology / Hematology, 34(2), 83–88. doi:10.1016/S1040-8428(00)00055-X